UMIN ID: UMIN000001574
Registered date:15/12/2008
Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Atherothrombotic disease |
Date of first enrollment | 2008/11/01 |
Target sample size | 250 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | To develop the monitoring techniques of poor-responder for clopidgrel |
---|---|
Secondary Outcome | Relationship of SNIP of CYP2C19 Relationship of DM |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1) Patients before operation 2) Cerebral infraction without embolization from the heart 3) Taking following drugs, warfarin, thrombolytic agents, heparin, etc. anti-platelet drugs except aspirin, clopidogrel or cilostazol (e.g., sarpogrelate, diryridamole, EPA, etc.) 4) Not eligible determind by the responding physician |
Related Information
Primary Sponsor | McLORDD, Coordinating Office |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Daiichi Sankyou |
Secondary ID(s) |
Contact
public contact | |
Name | Yuki Nishimura |
Address | 2-174, Edobashi, Tsu, MIE Japan |
Telephone | 059-231-5278 |
ynishimura@clin.medic.mie-u.ac.jp | |
Affiliation | Mie university hospital Clinical research support center |
scientific contact | |
Name | Masakatsu Nishikawa |
Address | 2-174, Edobashi, Tsu, MIE Japan |
Telephone | 059-231-5431 |
nisikawa@clin.medic.mie-u.ac.jp | |
Affiliation | Mie university faculty of medicine Institute of human research promotion and drug development |